Analyses of many CLL clones demonstrated that the IG gene rearrangements encoding the CLL B cell receptor (BCR) exhibit a striking skewed use of IGHV genes resulting in an IG repertoire different from that of normal B lymphocytes (3–5). The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.